(Q71169983)

English

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

scientific article published on 01 July 1996

Statements

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit